Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog

Liver Transplantation and Surgery

Volumn 4, Issue 2, 1998, Pages 158-165

  Nyberg, S L ^a   Cerra, F B ^a   Gruetter, R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; LACTIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; BRAIN LEVEL; BRAIN METABOLISM; BRAIN PERFUSION; CONTROLLED STUDY; DOG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTATE BLOOD LEVEL; LIVER FAILURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0031882282     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040203     Document Type: Article

References (48)

1. 1 Groenendaal F, Veehoven R, van der Grond J, Jansen G, Witkamp T, de Vries L. Cerebral lactate and n ‐acetyl‐aspartate/choline ratios in asphyxiated full‐term neonates demonstrated in vivo using proton magnetic resonance spectroscopy. Pediatr Res 1994 ; 35: 148–151. MEDLINE
2. 2 Ashwal S, Holshouser B, Tomasi LG, Shu S, Perkins R, Nystrom G, et al. 1H‐Magnetic resonance spectroscopy–determined cerebral lactate and poor neurological outcomes in children with central nervous system disease. Ann Neurol 1997 ; 41: 470–481. MEDLINE
3. 3 Sutton L, Wang Z, Duhaime A, Costarino D, Sauter R, Zimmerman R. Tissue lactate in pediatric head trauma: A clinical study using 1H NMR spectroscopy. Pediatr Neurosurg 1995 ; 22: 81–87. MEDLINE
4. 4 Cross J, Gadian D, Connelly A, Leonar J. Proton magnetic resonance spectroscopy studies in lactic acidosis and mitochondrial disorders. J Inherit Metab Dis 1993 ; 16: 800–811. MEDLINE
5. 5 Barkovich A, Good W, Koch T, Berg B. Mitochondrial disorders: Analysis of their clinical and imaging characteristics. Am J Neuroradiol 1993 ; 14: 1119–1137. MEDLINE
6. 6 Duncan D, Herholz K, Kugel H, Roth B, Ruitenbeek W, Heindel W, et al. Positron emission tomography and magnetic resonance spectroscopy of cerebral glycolysis in children with congenital lactic acidosis. Ann Neurol 1995 ; 37: 351–358. MEDLINE
7. 7 Felber S, Sperl W, Chemelli A, Murr C, Wendel U. Maple syrup urine disease: Metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol 1993 ; 33: 396–401. MEDLINE
8. 8 Auer R. Hypoglycemic brain damage (progress review). Stroke 1986 ; 17: 699–708. MEDLINE
9. 9 Hourani B, Hamlin E, Reynolds T. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med 1971 ; 127: 1033–1036. MEDLINE
10. 10 Chamuleau RA, Bosman DK, Bovee W, Luyten PR, den Hollander JA. What the clinician can learn from MR glutamine/glutamate assays. NMR Biomed 1991 ; 4: 103–108. MEDLINE
11. 11 Mariani P, Coudray‐Lucas C, Baudrimont M, Ribeiro J, Legendre C, Delelo R, et al. Glutamine metabolism and neuropathologic disorders in experimental hepatic encephalopathy: Effect of transplanted hepatocytes. Surgery 1996 ; 120: 93–99. MEDLINE
12. 12 McConnell JR, Antonson DL, Ong CS, Chu W‐K, Fox IJ, Heffron TG, et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995 ; 22: 69–74. MEDLINE
13. 13 Cordoba J, Gottstein J, Blei A. Glutamine, myo‐inositol, and organic brain osmolytes after portocaval anastomosis in the rat: Implications for ammonia‐induced brain edema. Hepatology 1996 ; 24: 919–923. MEDLINE
14. 14 Sielaff TD, Hu MY, Rollins MD, Bloomer JR, Amiot B, Hu W‐S, et al. An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology 1995 ; 21: 796–804. MEDLINE
15. 15 Haase A, Frahm J, Matthaei W, Hanicke W, Merboldt K. FALSH imaging. Rapid NMR imaging using low flip‐angle pulses. J Magn Reson 1986 ; 67: 258–266.
16. 16 Gruetter R. Automatic, localized in vivo adjustment of all first‐ and second‐order shim coils. Magn Reson Med 1993 ; 29: 804–811. MEDLINE
17. 17 Frahm J, Merboldt K, Hanicke W. Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987 ; 72: 502–508.
18. 18 Moonen C, van Zijl P. Highly effective water suppression for in vivo proton NMR spectroscopy (DRYSTREAM). J Magn Reson 1990 ; 88: 28–41.
19. 19 Gruetter R, Garwood M, Ugurbil K, Seaquist E. Observation of resolved glucose signals in 1H NMR spectra of the human brain at 4 Tesla. Magn Reson Med 1996 ; 36: 1–6. MEDLINE
20. 20 Choe B‐Y, Gil H‐J, Suh T‐S, Shinn K‐S. Postmortem metabolic and morphologic alterations of the dog brain thalamus with use of in vivo 1H magnetic resonance spectroscopy and electron microscopy. Invest Radiol 1995 ; 30: 269–274. MEDLINE
21. 21 Christensen E, Bremmelgaard A, Bahnsen M, Andreasen PB, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 1984 ; 19: 90–96. MEDLINE
22. 22 Caraceni P, Van Thiel D. Acute liver failure. Lancet 1995 ; 345: 163–169. MEDLINE
23. 23 Wijdicks EFM, Plevak DJ, Rakela J, Wiesner RH. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995 ; 70: 119–124. MEDLINE
24. 24 Munoz SJ, Robinson M, Northrup B, Bell R, Moritz M, Jarrell B, et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 1991 ; 13: 209–212. MEDLINE
25. 25 Blei A, Olafsson S, Webster S, Levy R. Complications of intracranial monitoring in fulminant hepatic failure. Lancet 1993 ; 341: 157–158. MEDLINE
26. 26 Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992 ; 16: 1–7. MEDLINE
27. 27 Bates TE, Williams SR, Kauppinen RA, Gadian DG. Observation of cerebral metabolites in an animal model of acute liver failure in vivo: A 1 H and 31 P nuclear magnetic resonance study. J Neurochem 1989 ; 53: 102–110. MEDLINE
28. 28 Moats R, Watson L, Shonk T, Tokuyama S, Braslau D, Eto R, et al. Added value of automated clinical proton MR spectroscopy of the brain. J Comput Assist Tomogr 1995 ; 19: 480–491. MEDLINE
29. 29 Morgan M. Noninvasive neuroinvestigation in liver disease. Semin Liver Dis 1996 ; 16: 293–314. MEDLINE
30. 30 Ross B, Danielsen E, Bluml S. Proton magnetic resonance spectroscopy: The new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 1996 ; 14: 30–39. MEDLINE
31. 31 Pujol J, Kulisevsky J, Moreno A, Deus J, Alonso J, Balanzo J, et al. [Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy.] Neurology 1996 ; 47: 1526–1530. MEDLINE
32. 32 Geissler A, Lock G, Frund R, Held P, Hollerbach S, Andus T, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997 ; 25: 48–54. MEDLINE
33. 33 Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997 ; 112: 1610–1616. MEDLINE
34. 34 Van Den Heuval A, Van der Grond J, Van Rooij L, Van Wassenaer‐van Hall H, Hoogenraad R, Mali W. Differentiation between portal‐systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H‐1 MR spectroscopy. Radiology 1997 ; 203: 539–543. MEDLINE
35. 35 Kreis R, Pfenninger J, Herschkowitz N, Boesch C. In vivo proton magnetic resonance spectroscopy in a case of Reye's syndrome. Intensive Care Med 1995 ; 21: 226–268. MEDLINE
36. 36 Gove C, Hughes R, Ede R, Williams R. Regional cerebral edema and chloride space in galactosamine‐induced liver failure in rats. Hepatology 1997 ; 25: 295–301. MEDLINE
37. 37 Brusilow S, Traystman R. To the editor [lett]. N Engl J Med 1986 ; 314: 786.
38. 38 Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991 ; 261: H825–H829. MEDLINE
39. 39 Olafsson S, Gottstein J, Andres TB. Brain edema and intracranial hypertension in rats after total hepatectomy. Gastroenterology 1995 ; 108: 1097–1103. MEDLINE
40. 40 Staub F, Baethmann A, Peters J, Weigt H, Kempski O. Effects of lactacidosis on glial cell volume and viability. J Cerebr Blood Flow Metab 1990 ; 10: 866–876.
41. 41 Freeman B, Crapo J. Biology of disease: Free radicals and tissue injury. Lab Invest 1982 ; 47: 412–426. MEDLINE
42. 42 Therrien G, Swain MS, Blei A, Butterworth R. Increased CSF lactate and neurological status in experimental hepatic encephalopathy [abs]. Hepatology 1991 ; 14: 248A.
43. 43 Sibson N, Dhankhar A, Mason G, Behar K, Rothman D, Shulman R. In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate‐glutamate cycling. Proc Natl Acad Sci USA 1997 ; 94: 2699–2704. MEDLINE
44. 44 Diaz‐Buxo J, Blumenthal S, Hayes D, Gores P, Gordon B. Galactosamine‐induced fulminant hepatic necrosis in unanesthetized canines. Hepatology 1997 ; 25: 950–957. MEDLINE
45. 45 Shi ZQ, Chang TMS. Amino acid disturbances in experimental hepatic coma rats. Int J Artif Organs 1984 ; 7: 197–202. MEDLINE
46. 46 Dixit V, Chang TMS. Brain edema and the blood brain barrier in galactosamine‐induced fulminant hepatic failure rats. ASAIO Trans 1990 ; 36: 21–27. MEDLINE
47. 47 Traber P, Ganger D, Brei A. Brain edema in rabbits with galactosamine‐induced fulminant hepatitis. Regional differences and effects on intracranial pressure. Gastroenterology 1986 ; 91: 1347–1356. MEDLINE
48. 48 Traber P, Canto M, Ganger D, Blei A. Electron microscopic evaluation of brain edema in rabbits with galactosamine‐induced fulminant hepatic failure: Ultrastructure and integrity of the blood‐brain barrier. Hepatology 1987 ; 7: 1272–1277. MEDLINE